drugset
Drugs / HLA-mismatched donor peripheral stem cell infusion
last change Jun 2018 re-read 3 minutes ago

HLA-mismatched donor peripheral stem cell infusion

Cell therapy

Developed for
acute myeloid leukemia
Investigated by
The Affiliated Hospital of the Chinese Academy of Military Medical Sciences

Trials 1

today NCT02171117 · Ph 3
20142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 3 NCT02171117 Mar 2014 → Jun 2018 acute myeloid leukemia The Affiliated Hospital of the Chinese Academy of Military Medical Sciences Unknown No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as HLA-mismatched donor peripheral stem cell infusion ClinicalTrials.gov intervention name — accepted as the source's own label NCT02171117 ↗
Modality Cell therapy “adoptive infusion of granulocyte colony stimulating factor (G-CSF) mobilized HLA-mismatched peripheral blood stem cells (GPBSC)” NCT02171117 ↗